MFDS — authorised 18 January 2008
- Marketing authorisation holder: JANSSEN R AND D
- Status: likely_approved
🇰🇷 Intelence in South Korea
MFDS authorised Intelence on 18 January 2008
Marketing authorisation
Intelence in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Intelence approved in South Korea?
Yes. MFDS authorised it on 18 January 2008.
Who is the marketing authorisation holder for Intelence in South Korea?
JANSSEN R AND D holds the South Korean marketing authorisation.